By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent reported after the close of the markets on Monday that revenues grew 16 percent during its fiscal second quarter, as its Electronics Measurement Group rebounded from recent woes to post an 18 percent bounce year over year.

Agilent reported total revenues of $1.27 billion for the three-month period ended April 30, compared to $1.09 billion for the second quarter of 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.